Determining EDC exposure: direct analytical methods are essential for accurate analysis of human biospecimens
Journal of the Endocrine Society · 07.04.2026 · 10 (5)
DOI: 10.1210/jendso/bvag076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 31.03.2026. Verfasst von Roy Gerona und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, CA 94134, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIEHS NIH HHS, NIH.
Abstract (Originalsprache)
Purpose
Estimates of human exposure are a major component of chemical risk assessment. Studies of bisphenol A (BPA) have raised concern that exposure has been underestimated because the lack of standards for the measurement of the major BPA metabolites has necessitated the use of flawed analytical tools to indirectly estimate them. Because other endocrine-disrupting chemicals (EDCs) are measured using similar indirect methods, we evaluated the accuracy of indirect analysis for representatives from three different classes of non-persistent EDCs that undergo rapid phase II metabolism: bisphenols, parabens, and phthalates.
Methods
A direct LC–MS/MS method that simultaneously measures bisphenol S (BPS), propyl paraben (PrP), and monobutyl phthalate (MBP), and their major metabolites in urine, was used to quantify these EDCs in sixty second-trimester human urine samples. The same samples were also analyzed with a widely used indirect method that requires enzymatic hydrolysis before estimating metabolite levels.
Results
Marked discrepancies were evident when maternal urine samples were analyzed by both direct and indirect methods. Indirect analysis underestimated levels of all three EDCs and BPA, with the magnitude of underestimation varying by analyte.
Conclusion
The accuracy of widely used “indirect” analytical methods that estimate metabolite levels in human urine is neither predictable nor consistent. Greater precision and accuracy is attained using authentic standards for metabolites. Given the importance of biomonitoring data in estimating human EDC exposure, analytical accuracy is critical. Availability of standards for both the parent compound and its major metabolites should be required before a chemical enters the marketplace.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, CA 94134, USA.
- Departments of Laboratory Medicine, University of California, San Francisco, CA 94107, USA.
- Division of Biological Sciences, University of Missouri-Columbia, Columbia, MO 65211, USA.
- School of Molecular Biosciences and Center for Reproductive Biology, Washington State University, Pullman, WA 99164, USA.
ORCID-Profile: Deborah French, Frederick S Vom Saal, Patricia Hunt
Förderung
- NICHD NIH HHS
- NIEHS NIH HHS
- NIH
Zitieren
APA
Gerona, R., Sovereign, A., French, D., Gonzaga, M. J., Vom Saal, F. S., & Hunt, P. (2026). Determining EDC exposure: direct analytical methods are essential for accurate analysis of human biospecimens. Journal of the Endocrine Society, 10(5). https://doi.org/10.1210/jendso/bvag076
Vancouver
Gerona R, Sovereign A, French D, Gonzaga MJ, Vom Saal FS, Hunt P. Determining EDC exposure: direct analytical methods are essential for accurate analysis of human biospecimens. Journal of the Endocrine Society. 2026;10(5). doi:10.1210/jendso/bvag076
BibTeX
@article{Gerona2026,
author = {Gerona, Roy and Sovereign, Alia and French, Deborah and Gonzaga, Mikayla Joyce and Vom Saal, Frederick S and Hunt, Patricia},
title = {Determining EDC exposure: direct analytical methods are essential for accurate analysis of human biospecimens},
journal = {Journal of the Endocrine Society},
year = {2026},
volume = {10},
number = {5},
doi = {10.1210/jendso/bvag076}
}
EUVIMED